中国实用儿科杂志

中国实用儿科杂志

• 指南解读 • 上一篇    下一篇

《2018美国心脏协会心肺复苏及心血管急救指南更新——儿童高级生命支持部分》解读

  

  1. 中国医科大学附属盛京医院PICU，辽宁  沈阳 110004
  • 出版日期:2019-02-06 发布日期:2019-03-08

Interpretation of 2018 American Heart Association Focused Update on Pediatric Advanced Life Support:An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

  1. Department of Pediatric Intensive Care Unit，Shengjing Hospital of China Medical University，Shenyang  110004，China
  • Online:2019-02-06 Published:2019-03-08

摘要：

2018年11月《美国心脏协会心肺复苏及心血管急救指南—儿童高级生命支持部分》进行了年度更新。2018年版新指南主要对儿童电击除颤难以纠正的心室颤动/无脉性室性心动过速的抗心律失常药物治疗进行了证据回顾并提出治疗建议。更新部分由国际复苏联络委员会儿科工作组进行了持续的临床证据审查。此次更新依然延续2015年的观点，即儿童电击除颤难以纠正的心室颤动/无脉性室性心动过速可使用抗心律失常药物利多卡因或胺碘酮治疗；同时，对儿童高级生命支持心脏骤停流程图略微调整。

关键词: 美国心脏协会, 高级生命支持, 儿童, 抗心律失常药物治疗

Abstract:

In November 2018，the American Heart Association（AHA） updated Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. The new guideline provided the evidence review and treatment recommendation for antiarrhythmic drug therapy in pediatric shock-refractory ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. The update was carried out by the Pediatrics Working Group of the International Liaison Committee on Resuscitation（ILCOR） for ongoing clinical evidence review. The update continues with the view of 2015’s edition that either lidocaine or amiodarone may be used to treat pediatric patients with shock-refractory ventricular fibrillation or pulseless ventricular tachycardia. The flow chart of cardiac arrest for pediatric advanced life support was slightly adjusted.

Key words: American Heart Association, advanced life support, child, antiarrhythmic drug therapy